DNA polymerase eta: A potential pharmacological target for cancer therapy - Saha - 2021 - Journal of Cellular Physiology - Wiley Online Library
Structural basis of accurate replication beyond a bulky major benzo[a]pyrene adduct by human DNA polymerase kappa - ScienceDirect
DNA Polymerase Kappa Antibody (6F2) (H00051426-M01): Novus Biologicals
Structural Basis for Human DNA Polymerase Kappa to Bypass Cisplatin Intrastrand Cross-Link (Pt-GG) Lesion as an Efficient and Accurate Extender - ScienceDirect
DNA polymerase eta: A potential pharmacological target for cancer therapy - Saha - 2021 - Journal of Cellular Physiology - Wiley Online Library
DNA polymerases and cancer | Nature Reviews Cancer
DNA polymerase eta protects human cells against DNA damage induced by the tumor chemotherapeutic temozolomide - ScienceDirect
DNA polymerase beta modulates cancer progression via enhancing CDH13 expression by promoter demethylation | Oncogene
In vivo evidence that DNA polymerase kappa is responsible for error-free bypass across DNA cross-links induced by mitomycin C - ScienceDirect
Molecules | Free Full-Text | Mammalian DNA Polymerase Kappa Activity and Specificity
Expression of the cancer-associated DNA polymerase ε P286R in fission yeast leads to translesion synthesis polymerase dependent hypermutation and defective DNA replication | PLOS Genetics
Unravelling roles of error-prone DNA polymerases in shaping cancer genomes | Oncogene
Translesion polymerase eta both facilitates DNA replication and promotes increased human genetic variation at common fragile sites | PNAS
Genes | Free Full-Text | Maintenance of Genome Integrity: How Mammalian Cells Orchestrate Genome Duplication by Coordinating Replicative and Specialized DNA Polymerases
DNA polymerase eta: A potential pharmacological target for cancer therapy - Saha - 2021 - Journal of Cellular Physiology - Wiley Online Library
Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy? | PLOS Genetics
DNA Polymerase Kappa Antibody (6F2) (H00051426-M01): Novus Biologicals
TLS Polymerases and Cancer - Current Research | Gustave Roussy
Frontiers | Inhibiting DNA Polymerases as a Therapeutic Intervention against Cancer